Sunday, November 22, 2015
Inside the Story of Cesca Therapeutics, the California Stem Cell Agency and its Kibosh of an $11 Million Proposal
The Sacramento Bee today carried a story taking a longer look at Cesca Therapeutics, Inc., its travails with the California stem agency and the firm’s application for $11 million to help finance a phase three clinical trial.
The freelance article was written by the publisher of this blog, David Jensen. Here is the full text of the story.Sphere: Related Content